PROBLEM TO BE SOLVED: To achieve the creation of a treatment agent for early ejaculation and/or delayed ejaculation of a new action mechanism.SOLUTION: The treatment agent for early ejaculation contains a compound having an NR2B subunit-containing NMDA receptor inhibition action as an active ingredient. A method for selecting the compound for treating early ejaculation or delayed ejaculation includes evaluation of an NR2B subunit-containing NMDA receptor inhibition action or activation action.COPYRIGHT: (C)2012,JPO&INPIT【課題】新規な作用機序の早漏及び/又は遅漏の治療薬の創製【解決手段】NR2Bサブユニットを含むNMDA受容体抑制作用を有する化合物を有効成分として含有する、早漏の治療剤。NR2B サブユニットを含むNMDA 受容体抑制作用または活性化作用を評価することを含む早漏または遅漏を治療するための化合物を選択する方法。【選択図】なし
